BNF:

6.6.2

Status:

Do Not Prescribe (DNP), Grey, Green - after consultant/specialist initiation

Decision Date:

None

Comments

GREEN after consultant/specialist initiation: 50mg tablets: use in post-menopausal women with breast cancer as per NICE NG101. (Decision date - December 2019)

Cost-effective to prescribe generically

GREY: 150mg tablets

DO NOT PRESCRIBE (DNP): Not to be prescribed by brand - Bondronat. (Decision date - August 2019)

 

search again